mRNA |
BRD-K61166597 |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
brivanib |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
R428 |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.7 |
mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.7 |
mRNA |
Obatoclax Mesylate |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
phloretin |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.7 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
cabozantinib |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.7 |
mRNA |
FQI-2 |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.7 |